Quantcast
Last updated on April 16, 2014 at 8:05 EDT

Latest Thrombosis Stories

2013-12-18 23:28:27

National network of lawyers will continue offer of these consultations through Christmas and New Year’s Day. Allegations being reviewed include migrations, perforation, filter fracture and other problems linked by FDA to life-threatening health problems. San Diego, CA (PRWEB) December 18, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html Resource4thePeople announced today that its national network of attorneys will be available over the upcoming holiday...

2013-12-17 08:25:52

Thrombosis & Haemostasis wins virtual contest celebrating agility, speed and endurance of scholarly journals PHILADELPHIA, Dec. 17, 2013 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the winner of the inaugural ScholarOne(®) Journal Triathlon, an online contest designed to celebrate and recognize the innovative practices of scholarly research...

2013-12-11 08:30:15

$1.7 million award supports University of Michigan collaboration with GlycoMimetics, Inc. ANN ARBOR, Mich., Dec. 11, 2013 /PRNewswire-USNewswire/ --- The University of Michigan has been awarded $1.7 million to collaborate with GlycoMimetics, Inc., to study a new class of anticoagulants to help millions of Americans at risk or venous thromboembolic disease (VTE), a serious blood-clotting disorder. The National Heart Lung and Blood Institute is supporting the three-year clinical trial...

2013-12-09 08:29:05

- VTE patients with cancer treated with once-daily edoxaban had a numerically lower incidence of recurrent VTE and a 36% lower risk of clinically relevant bleeding compared to warfarin in a subgroup analysis of the phase 3 Hokusai-VTE study(1) NEW ORLEANS and TOKYO, Dec. 9, 2013 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced results of a prespecified subgroup analysis of 771 cancer patients enrolled in the phase 3 Hokusai-VTE study. Patients with...

2013-12-03 23:31:15

On November 13, a new lawsuit was filed by a Wood County couple in West Virginia Southern District Court alleging that the woman was diagnosed with a blood clot in her left transverse sinus from NuvaRing. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing serious complications. San Diego, CA (PRWEB) December 03,...

2013-12-03 23:02:46

A NuvaRing lawsuit recently filed by Wright & Schulte contends that a 22-year old woman from Dayton developed bilateral pulmonary embolism and deep vein thrombosis due to her use of NuvaRing. This lawsuit also alleges that Organon was aware of the significant risk of these serious NuvaRing side effects and yet failed to warn the public about them. Columbus, OH (PRWEB) December 03, 2013 Wright & Schulte has recently filed a NuvaRing lawsuit on behalf of a 22-year-old woman from...

2013-11-26 23:32:23

Consumers continue to assert allegations of migrations, defects and other problems they claim lead to life-threatening health problems. Resource4thePeople announces it will maintain offer of free consultations over allegations of deep vein thrombosis, filter fracture, migration and perforation. San Diego, CA (PRWEB) November 26, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html Resource4thePeople announced today in its latest consumer update involving interior...

2013-11-26 08:27:14

LONDON, November 26, 2013 /PRNewswire/ -- BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena(TM) (polidocanol injectable foam) for the treatment of patients with incompetent veins and visible varicosities of the great saphenous vein (GSV) system.[1] Varithena(TM) (formerly known as Varisolve(R) PEM) is a pharmaceutical-grade, low-nitrogen, polidocanol foam dispensed from a...

2013-11-25 14:57:05

New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels. Critical limb ischemia (CLI) is a disease that severely obstructs arteries and reduces the blood flow to legs and feet. CLI remains an unmet clinical problem and with an ageing population and the rise in type II diabetes, the incidence of CLI is expected to increase. The study, led by academics in the University of Bristol's School of Clinical Sciences, is...

2013-11-21 23:30:55

Translational Sciences Inc. announces that StromAb is in production on Phase I Clinical Trials. (PRWEB) November 21, 2013 Translational Sciences Inc. announces that StromAb is in production on Phase I Clinical Trials. Production began after completing highly successful pre-clinical development studies showing exceptional efficacy and safety in multiple disease models. StromAb is a first-in-class antibody providing immediate safe dissolution of ACUTE blood clots that cause > 2 million...